ENLIGHTENMENT OF INTERNATIONAL CARBON EMISSION TRADING PRACTICE TO CHINA

In the era of "Post-epidemic" and "Dual-carbon targets", the focus of research on China's carbon trading market has changed from basic framework design to problem solving and development paths in the process of practice. Foreign carbon trading markets have developed for many years, and have experienced the financial crisis and the impact of the coronavirus epidemic. By analyzing the important problems and countermeasures encountered in the process of carbon trading market by representative organizations such as EU, USA, New Zealand, Korea and Japan, the valuable experience and reference significance of foreign carbon trading practice were summarized. At the same time, comparing the similarities and differences between Chinese and foreign carbon trading national conditions, and taking into account the current development of China's carbon trading market, this paper put forward some carbon trading strategies with Chinese characteristics and absorbing foreign advanced experience, such as choosing appropriate emission caps, balancing regulation, formulating price stabilization mechanism, and leaving interfaces for international cooperation. © 2023 Research Institute of Petroleum Processing, SINOPEC. All rights reserved.

ENLIGHTENMENT OF INTERNATIONAL CARBON EMISSION TRADING PRACTICE TO CHINA

In the era of "Post-epidemic" and "Dual-carbon targets", the focus of research on China's carbon trading market has changed from basic framework design to problem solving and development paths in the process of practice. Foreign carbon trading markets have developed for many years, and have experienced the financial crisis and the impact of the coronavirus epidemic. By analyzing the important problems and countermeasures encountered in the process of carbon trading market by representative organizations such as EU, USA, New Zealand, Korea and Japan, the valuable experience and reference significance of foreign carbon trading practice were summarized. At the same time, comparing the similarities and differences between Chinese and foreign carbon trading national conditions, and taking into account the current development of China's carbon trading market, this paper put forward some carbon trading strategies with Chinese characteristics and absorbing foreign advanced experience, such as choosing appropriate emission caps, balancing regulation, formulating price stabilization mechanism, and leaving interfaces for international cooperation. © 2023 Research Institute of Petroleum Processing, SINOPEC. All rights reserved.

Impact of COVID-19 Pandemic on the Frequency of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Background Respiratory virus infection is an important trigger of acute exacerbation of chronic obstructive pulmonary disease（AECOPD）. China has adopted a series of containment measures assisting to curb COVID-19 transmission since the outbreak of the pandemic. Several studies showed a decrease in hospitalizations for AECOPD during the COVID-19 pandemic. However，there has been a relative lack of studies investigating the effects of preventive measures on the frequency and severity of exacerbations. Objective To explore the impact of the COVID-19 pandemic on the frequency of AECOPD with or without medical attention. Methods The subjects were from a prospective COPD cohort study conducted in the First Affiliated Hospital of Guangzhou Medical University，which began recruiting patients in early 2016，with visits every 3 months to collect demographic and clinical data，including those who were followed up during June to August 2017（group 1），June to August 2018（group 2），June to August 2019 （group 3），and June to August 2020（group 4）. Basic clinical data （including the frequency of AECOPD，sex，age，symptom score and so on） were collected from group 1 from October 2016 to May 2017，group 2 from October 2017 to May 2018，group 3 from October 2018 to May 2019，and group 4 from October 2019 to May 2020（during which the periods from October 2019 to January 2020，and from February to May 2020 were defined as preCOVID-19 period，and post-COVID-19 period，respectively）. The frequency of AECOPD during October to May next year in group 4 was compared with that of the other three groups. The changes in the frequency of AECOPD between pre- and postCOVID-19 periods were analyzed. Results There were 162 patients in group 1，157 in group 2，167 in group 3，and 159 in group 4. Group 1 had a higher frequency of AECOPD in February to May than in October to January next year（P=0.013），so did group 2（P=0.016）. In contrast，group 4 had a higher frequency of AECOPD in October to January next year than in February to May（P=0.001）. The frequency of AECOPD during October to December in group 4 was similar to that of the other three groups（P>0.05）. But the frequency of AECOPD from February to April in group 4 was lower than that in groups 1-3 （P<0.05）. There was no significant difference in the monthly frequency of AECOPD without medical attention in group 4 compared with that of groups 1-3（P>0.05）. The frequency of AECOPD with medical attention from October to December in group 4 was similar to that of groups 1-3（P>0.05）. but it from February to April in group 4 was lower than that in groups 1-3（P<0.05）. Conclusion Prevention and control measures targeting COVID-19 may be contributive to reducing the frequency of AECOPD. It is suggested that COPD patients should reduce gathering activities，maintain social distance，wear masks when going out，and wash hands frequently even after the COVID-19. © 2023 Chinese General Practice. All rights reserved.

Impact of COVID-19 Pandemic on the Frequency of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Background Respiratory virus infection is an important trigger of acute exacerbation of chronic obstructive pulmonary disease（AECOPD）. China has adopted a series of containment measures assisting to curb COVID-19 transmission since the outbreak of the pandemic. Several studies showed a decrease in hospitalizations for AECOPD during the COVID-19 pandemic. However，there has been a relative lack of studies investigating the effects of preventive measures on the frequency and severity of exacerbations. Objective To explore the impact of the COVID-19 pandemic on the frequency of AECOPD with or without medical attention. Methods The subjects were from a prospective COPD cohort study conducted in the First Affiliated Hospital of Guangzhou Medical University，which began recruiting patients in early 2016，with visits every 3 months to collect demographic and clinical data，including those who were followed up during June to August 2017（group 1），June to August 2018（group 2），June to August 2019 （group 3），and June to August 2020（group 4）. Basic clinical data （including the frequency of AECOPD，sex，age，symptom score and so on） were collected from group 1 from October 2016 to May 2017，group 2 from October 2017 to May 2018，group 3 from October 2018 to May 2019，and group 4 from October 2019 to May 2020（during which the periods from October 2019 to January 2020，and from February to May 2020 were defined as preCOVID-19 period，and post-COVID-19 period，respectively）. The frequency of AECOPD during October to May next year in group 4 was compared with that of the other three groups. The changes in the frequency of AECOPD between pre- and postCOVID-19 periods were analyzed. Results There were 162 patients in group 1，157 in group 2，167 in group 3，and 159 in group 4. Group 1 had a higher frequency of AECOPD in February to May than in October to January next year（P=0.013），so did group 2（P=0.016）. In contrast，group 4 had a higher frequency of AECOPD in October to January next year than in February to May（P=0.001）. The frequency of AECOPD during October to December in group 4 was similar to that of the other three groups（P>0.05）. But the frequency of AECOPD from February to April in group 4 was lower than that in groups 1-3 （P<0.05）. There was no significant difference in the monthly frequency of AECOPD without medical attention in group 4 compared with that of groups 1-3（P>0.05）. The frequency of AECOPD with medical attention from October to December in group 4 was similar to that of groups 1-3（P>0.05）. but it from February to April in group 4 was lower than that in groups 1-3（P<0.05）. Conclusion Prevention and control measures targeting COVID-19 may be contributive to reducing the frequency of AECOPD. It is suggested that COPD patients should reduce gathering activities，maintain social distance，wear masks when going out，and wash hands frequently even after the COVID-19. © 2023 Chinese General Practice. All rights reserved.

Development of Machine Learning Regression Model for COVID-19 Drug Target Prediction

There is a perennial need to identify novel, effective therapeutic agents to combat rising infections. Recently, prediction of therapeutic targets to decrease the impact of COVID-19 has posed an urgent challenge requiring innovative solutions. Successful identification of novel drug-target combinations may greatly facilitate drug development. To meet this need, we developed a COVID-19 drug target prediction model using machine learning approaches to quickly identify drug candidates for 18 COVID-19 protein targets. Specifically, we analyzed the performance of three prediction models to predict drug-target docking scores, which represents the strength of interactions between ligands and proteins. Docking scores were predicted for 300,457 molecules on 18 different COVID-19 related protein docking targets. Our proposed approach achieved a competitive performance with mathrm{R}-{2}=0.69,MAE=0.285, MSE=0.627. In addition, we identify chemical structures associated with stronger binding affinities across target binding sites. We believe our work could potentially save pharmaceutical companies significant resources, especially during the early stages of drug development. © 2022 IEEE.

Pollution Characteristics and Risk Assessment of PPCPs in Typical Drinking Water Sources in the Middle Reaches of the Yangtze River During the COVID-19 Pandemic

During the CIVID-19 pandemic, water samples were collected from 26 sampling points in 18 typical drinking water sources in Wuhan, located in the middle reaches of the Yangtze River. Ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) methods were used to measure the concentrations of 31 pharmaceuticals and personal care products (PPCPs) in the water samples. The pollution characteristics of PPCPs were analyzed and their ecological and health risks were assessed. The results showed that a total of 23 PPCPs were detected in the 26 sampling points. Among them, five types of PPCPs were detected with a detection rate of 100%, with total concentrations ranging from 102.44 ng•L -1 to 745.78 ng•L -1, and the average concentration was 206.87 ng•L -1. The highest concentrations were in salicylic acid (SA) and doxycycline (DIC), ranging from 28.24 to 534.24 ng•L -1 and 28.72 to 416.6 ng•L -1, respectively. According to the spatial distribution of PPCPs, the concentration of antibiotics in the Hanjiang River was higher than that in the Yangtze River, whereas the concentration of other types of PPCPs in the Yangtze River was higher than that in the Hanjiang River. The ecological risk assessment results showed that the toxic risk in algae was higher than those in invertebrates and fish. The risks of salicylic acid (SA), doxycycline (DIC), lincomycin (LIN), and chlortetracycline (CTE) to algae were at a high level, and the ecological risk of PPCPs in the Hanjiang River was generally higher than that in the Yangtze River. The health risk assessment results showed that the risk to adults and children by drinking water ranged from 1.14 × 10 -4 to 0.136 and from 1.04 × 10 -4 to 0.821, respectively. The health risk to children was higher than that to adults, although their levels were low. Compared with the concentrations of PPCPs in drinking water sources of Wuhan in recent years, under the CIVID-19 pandemic, the pollution status of PPCPs in the Yangtze River was at a medium level, whereas it was at a high level in the Hanjiang River. © 2022 Science Press. All rights reserved.

Low Serum Albumin at Admission Is Associated with Mortality among Inpatients with Cirrhosis: A Multi-National Experience

Background: MELD and Child-Pugh scores have traditionally been used as prognostic indicators in patients with cirrhosis. Albumin infusions in outpatients have been associated with improved outcomes, but not in transplant waitlisted patients or inpatients. This aim of this study was to assess whether low serum albumin (sAlb) on admission alone is a poor prognostic indicator among cirrhotic inpatients from a new multi-national cohort. Method(s): The CLEARED study is a global study that enrolled consecutive non-electively admitted inpatients without organ transplant or COVID-19 from 6 continents. Admission demographics, medical history, laboratory data, inpatient course, death/hospice transfer and mortality at 30 days post-discharge were recorded. Patients were divided into 3 groups: sAlb <28gm/L(A), sAlb >=28 but <35gm/L (B), and sAlb>=35gm/L (C) were compared. Multi-variable logistic regression was performed using inpatient mortality and overall 30-day mortality as outcomes. Result(s): 2429 patients were enrolled from 21 countries worldwide. The distribution was A:49%, B:39%, C:12%. Gp A patients were significantly younger (54yrs vs. 57yrs vs 58yrs p<0.0001) but with similar gender distribution, and higher MELD-Na score of 25 vs. 20 vs. 17 (p<0.0001). Gp A patients were more likely to have alcohol as etiology of cirrhosis (49% vs. 45% vs 38%, p=0.004), and were more likely to have either infection (27% vs. 18% vs. 13%, p<0.0001), HE (39% vs. 33% vs. 23%, p=0.005) or fluid related issues as a reason for admission (p<0.0001). More patients in Gp A received albumin infusion during their hospital stay (120gm vs. 100gm vs. 100gm p=0.0004), mostly for the indications of AKI (47% vs. 49% vs. 47%, p=0.79) and performance of large volume paracentesis (44% vs. 42% vs. 41%, p=0.80), followed by bacterial peritonitis indication (22% vs. 17% vs. 11%, p=0.01). Group A patients had longer hospital stays (9 days vs. 8 days vs. 7 days (p<0.001), but similar ICU transfer (23% vs. 22% vs. 20%, p=0.55). group A patients were more likely to die while inpatients (19% vs. 11% vs. 5%, p<0.0001), or by 30 days post-discharge (29% vs. 20% vs. 9%, p<0.0001). Table shows the admission variables associated with a poor outcome. Conclusion(s): Hypoalbuminemia is extremely common among admitted cirrhotic patients, with sAlb of <28gm/L occurring in almost half. Together with MELD-Na score and infection at admission, a low sAlb is associated with a poor outcome in these patients. Future studies will need to validate these findings and to assess whether albumin infusions will improve the outcome of these patients. (Figure Presented).

Differences in Mortality Rates in Inpatients with Cirrhosis Depends on the Low, Middle or High Income Country Location: Multi-National Cleared Consortium Experience

Background: Although cirrhosis is a major cause of mortality worldwide, there could be disparities in outcomes. This needs a global consortium to study disparities in inpatient cirrhosis care Aim: Define the impact of location in prediction of outcomes in inpts with cirrhosis. Method(s): CLEARED prospectively enrolled non-electively admitted cirrhosis pts without COVID from all continents. To ensure equity, we allowed only 50 pts/site. Admission details, cirrhosis history, inpatient & 30-day course were recorded. World bank classification of low/low middle income (LMI), upper middle (UMI) & High income (HI) were used. Cirrhosis details, inpatient & 30-day outcomes were compared between groups. Multi-variable regression was performed using inpatient & 30-day mortality as outcomes. Result(s): 2758 pts from 21 countries from all continents, including Africa & Australia, were included.727 were L/LMI, 1050 UMI & 981 pts were from HICs. More men & younger pts were in LMI. Cirrhosis details: More pts in HI gp had 6M hospitalizations & infections, HE & ascites while prior variceal bleeding was higher in LMI . Prior HCC & transplant listings were lower in LMI but similar in UMI/HI. Alcohol & NASH was highest in HI. Viral hepatitis & cryptogenic were highest in UMI.Admissions: Admission MELD was highest in LMI. LMI pts were admitted more for GI Bleed, HE, & DILI, while anasarca & HBV flares were higher in UMI. Higher SBP (36% vs 24% vs 21% p<0.0001) & lowest skin/soft-tissue infections were in LMI (5% vs 5% vs 10% p=0.008);rest were similar. Nosocomial infections, driven by UTI were highest in LMI & HI pts (15% vs 14% vs 11% UMI, p=0.03). Admission diuretics, PPIs, Lactulose & statins were highest & antivirals lower in HI. SBP prophylaxis & rifaximin were highest in LMI pts. Outcome(s): More LMI pts needed ICU & had more organ failures (Fig B). Discharge MELD was highest in LMI. In-hospital mortality was highest & transplant lowest in LMI. This extended to 30-day mortality & transplant in LMI patients vs HI pts.Regression: In-hospital mortality was linked with age, infections, MELD & being in a LMI/UMI vs HIC while being on a transplant list, diabetes, & SBP prophylaxis were protective (Fig C). 30-day mortality predicted by age, ascites, HCC, discharge MELD, organ failures, LMI/UMI vs HIC but rifaximin was protective(Fig D). In-hospital transplant was higher with high MELD, admission rifaximin & listed pts &lower in LMI (OR 0.26) & UMI (OR 0.22) & age. 30-day transplant was higher in those with hyponatremia, ascites & HRS, on the list & on rifaximin and lower in LMI (OR 0.24) & UMI (OR 0.59) vs HI. Conclusion(s): In a global study of inpatients with cirrhosis, there were major differences in outcomes. Not being in a high-income country significantly increased the risk of inpatient and 30-day mortality independent of demographics, medications, in-hospital course, and cirrhosis severity likely due to disparities in access to transplant, which should be accounted for in global models. (Figure Presented).

An online database of English assessment tasks for developing student teachers' assessment literacy

This paper reports a project that developed an online database of English assessment tasks for schools (assesslang.eduhk.hk). The project adopted a design-based approach. During the design phase, 92 student teachers designed language tests in groups;their designs were annotated with detailed task features before being moved to the open database. Two evaluative studies were conducted in 2018 (N = 48) and 2021 (N = 35) through a questionnaire;both studies found the participants showed a positive attitude toward the innovation but also uncovered several remaining issues through individual interviews (N = 10). Counter-intuitively, the 2021 cohort, whose learning experience had been compromised substantially due to the pandemic, was found to show more positive attitudes than the 2018 cohort. This finding along with others is discussed to inform researchers and educators elsewhere who are interested in harnessing the power of technology to develop student teachers' language assessment literacy in an even more challenging post-Covid era. Copyright © 2022 Inderscience Enterprises Ltd.

CLEARED Global consortium results highlight regional variation and need for equity in inpatient outcomes in hospitalized patients with Chronic Liver Disease

Background and aims: A global study with equitable participation for cirrhosis and chronic liver disease (CLD) outcomes is needed. We initiated the Chronic Liver disease Evolution And Registry for Events and Decompensation (CLEARED) study to provide this global perspective. Aim to evaluate determinants of inpatient mortality and organ dysfunction in a multi-center worldwide study. Method: We prospectively enrolled pts with CLD/Cirrhosis >18 years without organ transplant or COVID-19 who were admitted non-electively. To maintain equity in outcome analysis, a maximum of 50 pts/site were allowed. Data for admission variables, hospital course, and inpatient outcomes (ICU, death, organ dysfunction [ODF]) were recorded. This was analyzed for death and ODs using significant variables on admission and including World Bank classification of low/middle-income countries (LMIC). A model for in-hospital mortality for all variables during the hospital course, including ODs) was analyzed. Results: 1383 pts (55 ± 13 yrs, 64% men, 39% White, 30% Asian, 10% Hispanic, 9% Black, 12% other) were enrolled from 49 centers (Fig A). 39% were from high-income while the rest were from LMICs. Admission MELDNa 23 (6–40) with history in past 6 months of hospitalizations 51%, infections 25%, HE 32%, AKI 23%, prior LVP 15%, hydrothorax 8% and HCC 4%. Leading etiologies were Alcohol 46% then NASH 23%, HCV 11% and HBV 13%. Most were on lactulose 52%, diuretics 53%, PPI 49% and statins 11%, SBP prophylaxis 16%, beta-blockers 35% and rifaximin 31%. 90% were admitted for liver-related reasons;GI bleed 30%, HE 34%, AKI 33%, electrolyte issues 30%, anasarca 24% and 25% admission infections. In-hospital course: Median LOS was 7 (1–140) days with 25% needing ICU. 15% died in hospital, 3% were transplanted, 46% developed AKI,15% grade 3–4 HE, 14% shock, 13% nosocomial infections and 13% needed ventilation. Logistic Regression: Fig B shows that liver-related/unrelated factors on admission which predicted in-hospital mortality and development of organ dysfunction with MELDNa and Infections being common among all models. Nosocomial infections and organ dysfunctions predicted mortality when all variables were considered. High-income countries had better mortality outcomes likely due to transplant and ICU availability. AUCs were >0.75 (Figure Presented) Conclusion: In this worldwide equitable experience, admission cirrhosis severity and infections are associated with inpatient outcomes, which are greater in low-income settings. Liver-related and unrelated factors and regional variations are important in defining critical care goals and outcome models in inpatients with cirrhosis.

The price fluctuation in Chinese carbon emission trading market: New evidence from adaptive Fourier decomposition

This paper studies the carbon price fluctuation in China through the adaptive Fourier decomposition (AFD). Apart from the transient time-frequency distribution of the original AFD model, we also reconstruct the mono-components of this model to obtain the components in different time-frequency scales. Our empirical results based on the carbon price in Hubei Province demonstrate that there are three periods when the price fluctuates dramatically, mainly affected by the governmental policies about carbon emission and the development of clean energies, as well as the outbreak of COVID-19. Furthermore, the fluctuations of the price in the three identified periods are reflected in different scales. The comparison of the decomposition results and those of EMD and VMD shows that the AFD performs best in absorbing the price's useful information extracted through all these methods. © 2021 The Authors. Published by Elsevier B.V.

Overview and applications of master protocol in clinical trials

Master protocol is a novel and more efficient design for clinical trial research than the traditional clinical trials. Usually a master protocol includes several sub-protocols which could investigate treatment effects of a single drug on several diseases or multiple drugs targeting a single disorder. This review compared master protocol with traditional trials in terms of the research design principle, application, and procedure flow as well as advantages and limitations. We also presented some examples of ongoing applications of master protocol designs including treatment of COVID-19 related illness. Finally, we discussed about potential implementation of master protocol in China especially under the COVID-19 pandemic with an evaluation on the relevant opportunities and challenges. © 2021, Chinese Journal of New Drugs Co. Ltd. All right reserved.

Municipal solid waste management under Covid-19: Challenges and recommendations

Covid-19 is proving to be an unprecedented disaster for human health, social contacts and the economy worldwide. It is evident that SARS-CoV-2 may spread through municipal solid waste (MSW), if collected, bagged, handled, transported or disposed of inappropriately. Under the stress placed by the current pandemic on the sanitary performance across all MSW management (MSWM) chains, this industry needs to re-examine its infrastructure resilience with respect to all processes, from waste identification, classification, collection, separation, storage, transportation, recycling, treatment and disposal. The current paper provides an overview of the severe challenges placed by Covid-19 onto MSW systems, highlighting the essential role of waste management in public health protection during the ongoing pandemic. It also discusses the measures issued by various international organisations and countries for the protection of MSWM employees (MSWEs), identifying gaps, especially for developing countries, where personal protection equipment and clear guidelines to MSWEs may not have been provided, and the general public may not be well informed. In countries with high recycling rates of MSW, the need to protect MSWEs' health has affected the supply stream of the recycling industry. The article concludes with recommendations for the MSW industry operating under public health crisis conditions. © 2021 ICE Publishing: All rights reserved.

Preliminary study of serum 2019-nCoV IgM and IgG antibodies in the diagnosis of COVID-19

Objective: To analyze the clinical value of serum 2019 novel coronavirus (2019-nCoV) immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies in the diagnosis of COVID-19. Methods: A total of 116 patients diagnosed with NCP in the First Affiliated Hospital of Hunan University of Chinese Medicine and the First Affiliated Hospital of Xiamen University were enrolled from January to February 2020 as the disease group. A total of 134 cases, including 84 non-NCP inpatients and 50 healthy individuals served as the control group. Serum samples from all subjects were collected. A fully-automated chemiluminescence immunoassay analyzer was used to detect the concentration of 2019-nCoV IgM and IgG antibodies in serum. The sensitivity and specificity of the 2019-nCoV IgM and IgG antibody single test and combined detection were compared using the χ2 test. χ2 test and Wilcoxon's rank sum test were used to compare the positive rates and concentrations of IgM and IgG antibodies in NCP patients before and after their 2019-nCoV nucleic acid tests turning negative, respectively. The change trend of 2019-nCoV antibody concentration in the process of NCP patients was analyzed by Wilcoxon's rank sum test. Results: The sensitivity of 2019-nCoV IgG (90.5%, 105/116) was higher than that of 2019-nCoV IgM (75.9%, 88/116), the difference was statistically significant (χ2=8.91, P<0.05);The specificity of 2019-nCoV IgG (99.3%,133/134) was higher than that of 2019-nCoV IgM (94.0%, 126/134), the difference was statistically significant (χ2=5.63,P<0.05). The sensitivity (89.7%,87/97) of 2019-nCoV IgM combined with IgG was higher than that of 2019-nCoV IgM, the difference was statistically significant (χ2=6.89,P<0.05). The specificity (100%, 125/125) of 2019-nCoV IgM combined with IgG was higher than that of 2019-nCoV IgM, the difference was statistically significant (χ2=7.70, P<0.05). After 2019-nCoV nucleic acid test converted to negative, the positive rate (9/17) and concentration [13.0 (4.9, 24.7) AU/ml] of serum 2019-nCoV IgM antibody were significantly lower than those when the nucleic acid test was positive, positive rate (15/17) and concentration [29.5 (14.0, 61.3) AU/ml], respectively (χ2=5.10, Z=-3.195, both P<0.05). In the course of NCP, patients' serum samples were collected from the first day of diagnosis to every three days, three times in total. The first 2019-nCoV IgM and IgG antibody concentrations [19.4 (12.4, 63.7) AU/ml, 105.8 (74.8, 126.1) AU/ml, respectively] were significantly higher than the second concentrations [15.8 (7.1, 40.3)AU/ml, 80.5 (66.7, 105.9) AU/ml], Z were-2.897,-3.179, both P<0.05. Conclusions: 2019-nCoV IgG antibody has a good application value in the diagnosis of NCP. The concentration of 2019-nCoV IgM antibody has a certain correlation with the detection of 2019-nCoV nucleic acid. The combination of 2019-nCoV IgM and IgG antibodies with 2019-nCoV nucleic acid test may be the best laboratory index for the diagnosis of NCP at present.

[The role of large-scale testing platform in the prevention and control of the COVID-19 pandemic: an empirical study based on a novel numerical model].

Objective: China adopted an unprecedented province-scale quarantine since January 23rd 2020, after the novel coronavirus (COVID-19) broke out in Wuhan in December 2019. Responding to the challenge of limited testing capacity, large-scale (>20 000 tests per day) standardized and fully-automated laboratory (Huo-Yan) was built as an ad-hoc measure. There is so far no empirical data or mathematical model to reveal the impact of the testing capacity improvement since quarantine. Methods: Based on the suspected case data released by the Health Commission of Hubei Province and the daily testing data of Huo-Yan Laboratory, the impact of detection capabilities on the realization of "clearing" and "clearing the day" of supected cases was simulated by establishing a novel non-linear and competitive compartments differential model. Results: Without the establishment of Huo-Yan, the suspected cases would increase by 47% to 33 700, the corresponding cost of quarantine would be doubled, the turning point of the increment of suspected cases and the achievement of "daily settlement" (all newly discovered suspected cases are diagnosed according to the nucleic acid testing result) would be delayed for a whole week and 11 days. If the Huo-Yan Laboratory could ran at its full capacity, the number of suspected cases could start to decrease at least a week earlier, the peak of suspected cases would be reduced by at least 44%, and the quarantine cost could be reduced by more than 72%. Ideally, if a daily testing capacity of 10 500 tests was achieved immediately after the Hubei lockdown, "daily settlement" for all suspected cases could be achieved. Conclusions: Large-scale, standardized clinical testing platform, with nucleic acid testing, high-throughput sequencing, and immunoprotein assessment capabilities, need to be implemented simultaneously in order to maximize the effect of quarantine and minimize the duration and cost of the quarantine. Such infrastructure, for both common times and emergencies, is of great significance for the early prevention and control of infectious diseases.